FDAnews Device Daily Bulletin

NEWARK BETH ISRAEL MEDICAL CENTER SEEKS HEART FAILURE PATIENTS FOR INVESTIGATIONAL STUDY EVALUATING USE OF NEW IMPLANTABLE PULSE GENERATOR

Dec. 8, 2005
A A

Newark Beth Israel Medical Center today announced it is enrolling patients in a clinical study to investigate the safety and effectiveness of a new implantable pulse generator called the Optimizer. The Optimizer System is designed to deliver electrical impulses to the heart for treatment of moderate to severe heart failure. This study of the Optimizer System is sponsored by Impulse Dynamics (USA) Inc., a specialty medical device company located in New York and a wholly-owned subsidiary of Impulse Dynamics N.V. Newark Beth Israel Medical Center is an affiliate of the Saint Barnabas Health Care System.
PR Newswire